Archives
-
Antiepileptic Drugs and Human Aromatase Inhibition
2026-09-25
Jacobsen and colleagues screened 12 antiepileptic drugs for effects on human aromatase (CYP19), identifying inhibition by seven compounds while finding no detectable inhibition by Primidone under the assay conditions. The study also tested selected drug combinations, offering a focused in vitro framework for assessing whether antiepileptic therapy could affect estrogen synthesis, while leaving clinical causality unresolved.
-
Carbapenemase Transfer in Guangdong CREC
2026-09-25
A multicentre study of 54 carbapenem-resistant Enterobacter cloacae isolates from eight Guangdong teaching hospitals mapped carbapenemase genes to chromosomes and plasmids and tested their transferability. The findings show frequent blaNDM-1 carriage, substantial multidrug resistance among gene-positive isolates, and efficient transfer in laboratory conjugation assays—evidence relevant to surveillance, but not proof of transmission routes between patients or hospitals.
-
DAPT (GSI-IX) in Human Neuron Assay Design
2026-09-24
DAPT (GSI-IX) can help researchers probe γ-secretase-dependent biology, but results in human sensory-neuron models require careful separation of neuronal development, viral latency, and reactivation. This article connects a validated hiPSC-derived HSV-1 latency system with a rigorous framework for testing DAPT without implying effects the study did not measure.
-
Phenylalanine Nanostructures Sensitize Tumours to ICB
2026-09-24
A study in Nature Nanotechnology reports that metal-ion-chelating l-phenylalanine nanostructures activate dendritic cells through ion flux, NF-κB signalling and the NLRP3 inflammasome. In tumour models, combining the nanostructures with short-term starvation promoted immune responses and improved the rationale for pairing this approach with immune checkpoint blockade.
-
MLKL Polymerization Drives Lysosomal Permeabilization
2026-09-23
Liu and colleagues show that polymerizing MLKL reaches lysosomal membranes and promotes lysosomal membrane permeabilization before plasma membrane rupture during necroptosis. Their experiments identify cathepsin B as an important contributor to cell death and clarify a lysosome-centered step in the pathway, while leaving open how broadly the mechanism applies across cell types and disease settings.
-
Cinoxacin: From DNA Stress to Translational Strategy
2026-09-23
A mechanistic and strategic guide to using Cinoxacin in Gram-negative infection models, urinary tract infection research, bacterial prostatitis research, and antibiotic resistance studies.
-
TAK-715: Rethinking p38α Inflammation Research
2026-09-22
TAK-715 offers a selective way to interrogate p38α-driven cytokine biology while opening a broader translational question: can kinase inhibitors influence not only catalytic activity, but also the conformational states that determine phosphatase access? This article connects TAK-715 pharmacology with emerging p38α dephosphorylation biology and outlines a practical strategy for inflammation and rheumatoid arthritis research.
-
PreScission Protease (PSP) Tag Cleavage Guide
2026-09-22
PreScission Protease (PSP), SKU K1101, is an HRV 3C protease fusion enzyme for site-specific removal of affinity tags from recombinant proteins at low temperature. It should be used only when the target construct contains the recognized cleavage sequence and should not be treated as a general-purpose protease for proteins lacking that site.
-
Amyloid β-Peptide (1-42): Assay Design
2026-09-21
Explore how Amyloid β-Peptide (1-42) can be used in state-aware neurotoxicity, microglial, and ion-channel assays. This guide translates foundational evidence into practical decisions about peptide preparation, aggregation, controls, and endpoint selection.
-
GSK126 EZH2 Inhibitor: Mechanism and Research Use
2026-09-21
GSK126 is a potent, selective EZH2 inhibitor that targets PRC2-dependent H3K27me3 formation. Its reported 93 pM Ki, activity in EZH2-mutant lymphoma models, and compatibility with mechanistic cell assays make it a useful tool for cancer epigenetics research and oncology drug development.
-
Methoxy-X04 Workflows for Amyloid Imaging
2026-09-20
Methoxy-X04 converts amyloid pathology into a practical fluorescence endpoint for plaque mapping, cerebrovascular amyloid visualization, and treatment-response studies. This workflow shows how to connect brain-accessible imaging with rTMS experiments while separating true biological change from staining and optical artifacts.
-
Masitinib (AB1010): KIT/PDGFR Workflow Guide
2026-09-19
Masitinib (AB1010) is a DMSO-compatible phenylaminothiazole-type tyrosine kinase inhibitor for focused studies of KIT, PDGFRα, PDGFRβ, mast-cell responses, and GIST models. This guide explains how to set up and QC assays when no directly matched paper protocol is available; it is not intended for aqueous or ethanol-based workflows, broad-spectrum kinase profiling, or clinical treatment.
-
Metabolism of Sumatriptan Revisited: CYP and MAO
2026-09-18
Pöstges and Lehr revisited the accepted metabolic pathway of sumatriptan using recombinant human cytochrome P450 and monoamine oxidase enzymes with HPLC–MS analysis. Their results show that CYP1A2, CYP2C19, and CYP2D6 can initiate N-demethylation, while MAO A further oxidatively deaminates sumatriptan and its desmethyl metabolites, indicating that the pathways are complementary rather than mutually exclusive.
-
Methoxy-X04 for Mechanism-Resolved Aβ Imaging
2026-09-18
Methoxy-X04 is a brain-permeable fluorescent amyloid beta probe for resolving plaque, oligomeric, and cerebrovascular amyloid signals in Alzheimer’s models. This article presents an assay framework that connects amyloid imaging with rTMS-driven microglial clearance while separating fluorescence changes from claims about mechanism.
-
Tricine-SDS-PAGE Gel Preparation Kit Guide
2026-09-17
The Tricine-SDS-PAGE Gel Preparation Kit is intended for researchers who need improved resolution of low-molecular-weight proteins and peptides that can be difficult to resolve with conventional Tris-SDS-PAGE. It supports denaturing or non-denaturing electrophoresis workflows when sample preparation and running conditions are selected appropriately, but it is intended only for scientific research and not for diagnostic or medical use.